U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849219) titled 'Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia' on Feb. 23.
Brief Summary: Trigeminal neuralgia is a debilitating neurological condition, affecting quality of life in most affected patients. Carbamazepine has traditionally been used for the management of this condition, but it has a moderate effectiveness and a poor side-effect profile. Oxcarbazepine is more tolerable, and has a more favorable side-effect profile. This study aims to compare the effectiveness of oxcarbazepine and carbamazepine in the management of this condition, for improved prescription practices in the future.
Study Sta...